IMMIX BIOPHARMA INC's ticker is and the CUSIP is 45258H106. A total of 17 filers reported holding IMMIX BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146,923 | +27.1% | 42,960 | 0.0% | 0.00% | – |
| Q2 2023 | $115,562 | +47.8% | 42,960 | 0.0% | 0.00% | – |
| Q1 2023 | $78,187 | -60.3% | 42,960 | -50.0% | 0.00% | – |
| Q4 2022 | $196,756 | +239.2% | 85,920 | +100.0% | 0.00% | – |
| Q3 2022 | $58,000 | -42.0% | 42,960 | +11.4% | 0.00% | – |
| Q2 2022 | $100,000 | – | 38,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Imprint Wealth LLC | 23,083 | $78,944 | 0.07% |
| Moss Adams Wealth Advisors LLC | 20,000 | $68,400 | 0.02% |
| Koshinski Asset Management, Inc. | 51,001 | $174,423 | 0.02% |
| InterOcean Capital Group, LLC | 15,900 | $54,378 | 0.00% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 12,000 | $41,040 | 0.00% |
| Tortoise Investment Management, LLC | 1,300 | $4,446 | 0.00% |
| WELLS FARGO & COMPANY/MN | 57 | $195 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 73,022 | $249,805 | 0.00% |
| STATE STREET CORP | 42,960 | $146,923 | 0.00% |